Select Page

Hememics Biotechnologies and General Graphene Corporation form strategic partnership for graphene biosensors

Earlier this month, Hememics Biotechnologies, developer of a rapid handheld bio testing platform based on unique graphene-based sensors, raised a $2 million seed round to help build its “lab in a hand” tech. Now, Hememics Biotechnologies also entered into a strategic...

Versarien reports interim results after “challenging period”; plans to regroup around Cementene and Graphene wear

Versarien plans to regroup around its commercial graphene applications (Cementene and Graphene Wear) in order to promote a recovery, while also cutting costs to stabilize the business, as the Company stated while also reporting its interim results. In the results...

GrapheneDx, General Graphene Corp and Sapphiros announce strategic partnership to industrialize graphene-based biosensors

GrapheneDX, General Graphene Corporation and Sapphiros have announce a strategic partnership to industrialize graphene-based biosensors for medical devices used to diagnose a variety of diseases at the point-of-care and in consumer settings. GrapheneDx is an in vitro...